186 related articles for article (PubMed ID: 30965682)
1. In Vitro and in Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2.
Haidar S; Aichele D; Birus R; Hielscher J; Laitinen T; Poso A; Jose J
Molecules; 2019 Apr; 24(7):. PubMed ID: 30965682
[TBL] [Abstract][Full Text] [Related]
2. Natural Compounds Isolated from
Haidar S; Jürgens FM; Aichele D; Jagels A; Humpf HU; Jose J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361605
[TBL] [Abstract][Full Text] [Related]
3. In Silico and In Vitro Studies of Natural Compounds as Human CK2 Inhibitors.
Haidar S; Jürgens F; Aichele D; Jose J
Curr Comput Aided Drug Des; 2021; 17(2):323-331. PubMed ID: 32160849
[TBL] [Abstract][Full Text] [Related]
4. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
Pucko E; Ostrowski R; Matyja E
Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 2 (4`-hydroxynaphthyl) chromen-4-one as a CK2 inhibitor.
Haidar S; Jabbour M; Al-Khayat MA; Aichele D; Jose J
Pharmazie; 2018 Apr; 73(4):191-195. PubMed ID: 29609684
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
Guerra B; Hochscherf J; Jensen NB; Issinger OG
Mol Cell Biochem; 2015 Aug; 406(1-2):151-61. PubMed ID: 25963666
[TBL] [Abstract][Full Text] [Related]
7. QSAR Model of Indeno[1,2-
Haidar S; Marminon C; Aichele D; Nacereddine A; Zeinyeh W; Bouzina A; Berredjem M; Ettouati L; Bouaziz Z; Le Borgne M; Jose J
Molecules; 2019 Dec; 25(1):. PubMed ID: 31888043
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin.
Cozza G; Zonta F; Dalle Vedove A; Venerando A; Dall'Acqua S; Battistutta R; Ruzzene M; Lolli G
FEBS J; 2020 May; 287(9):1850-1864. PubMed ID: 31661600
[TBL] [Abstract][Full Text] [Related]
9. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
[TBL] [Abstract][Full Text] [Related]
10. Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
Liu S; Hsieh D; Yang YL; Xu Z; Peto C; Jablons DM; You L
BMC Pharmacol Toxicol; 2013 Jul; 14():36. PubMed ID: 23845105
[TBL] [Abstract][Full Text] [Related]
11. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
[TBL] [Abstract][Full Text] [Related]
12. Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking.
Di-wu L; Li LL; Wang WJ; Xie HZ; Yang J; Zhang CH; Huang Q; Zhong L; Feng S; Yang SY
J Mol Graph Model; 2012 Jun; 36():42-7. PubMed ID: 22516037
[TBL] [Abstract][Full Text] [Related]
13. The halogenation of natural flavonoids, baicalein and chrysin, enhances their affinity to human protein kinase CK2.
Marzec E; Świtalska M; Winiewska-Szajewska M; Wójcik J; Wietrzyk J; Maciejewska AM; Poznański J; Mieczkowski A
IUBMB Life; 2020 Jun; 72(6):1250-1261. PubMed ID: 32364671
[TBL] [Abstract][Full Text] [Related]
14. TF--a novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP.
Götz C; Gratz A; Kucklaender U; Jose J
Biochim Biophys Acta; 2012 Jul; 1820(7):970-7. PubMed ID: 22387500
[TBL] [Abstract][Full Text] [Related]
15. Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modification.
Sun H; Xu X; Wu X; Zhang X; Liu F; Jia J; Guo X; Huang J; Jiang Z; Feng T; Chu H; Zhou Y; Zhang S; Liu Z; You Q
J Chem Inf Model; 2013 Aug; 53(8):2093-102. PubMed ID: 23937544
[TBL] [Abstract][Full Text] [Related]
16. N-substituted Indole-2 and 3-carboxamide derivatives as inhibitors of human protein kinase CK2: in vitro assay and molecular modelling study.
Olgen S; Gratz A; Kurt ZK; Jose J
Acta Chim Slov; 2013; 60(3):628-35. PubMed ID: 24169717
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel CK2 leads by cross-docking based virtual screening.
Sun H; Wu X; Xu X; Jiang Z; Liu Z; You Q
Med Chem; 2014; 10(6):628-39. PubMed ID: 24286395
[TBL] [Abstract][Full Text] [Related]
18. Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor.
Jin CH; Jun KY; Lee E; Kim S; Kwon Y; Kim K; Na Y
Bioorg Med Chem; 2014 Sep; 22(17):4553-65. PubMed ID: 25131958
[TBL] [Abstract][Full Text] [Related]
19. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
20. A new family of densely functionalized fused-benzoquinones as potent human protein kinase CK2 inhibitors.
Martín-Acosta P; Haider S; Amesty Á; Aichele D; Jose J; Estévez-Braun A
Eur J Med Chem; 2018 Jan; 144():410-423. PubMed ID: 29288942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
